County to Begin Shuttering COVID-19 Monoclonal Antibody Treatment Centers

Konu Başlıkları

San Diego County pandemic
A treatment room at a South Bay Monoclonal Antibody Regional Centers. Photo credit: County News Center

As the number of reported cases of COVID-19 continues to decrease and hospitals in the region have built more capacity for treatment of the virus, San Diego County announced Friday it will begin closing its Regional Monoclonal Antibody Treatment operations.

Three of the four operating Monoclonal Antibody Regional Centers will close by the end of this month, according to the county Health and Human Services Agency. Family Health Centers of San Diego will continue to provide monoclonal antibodies for prevention and for treatment, by appointment only.

“The demand for monoclonal antibody treatment has been steadily decreasing in recent months as COVID-19 treatments, including Paxlovid, have become readily available at medical providers’ offices and other locations,” said Dr. Wilma J. Wooten, county public health officer. “County Public Health will continue to monitor the pandemic to ensure the community’s treatment needs are met.”

Since the centers opened in February 2021, nearly 15,000 patients have been treated with monoclonal antibodies at 10 locations across the region. The development of the MARCs, prior to the availability of antiviral COVID-19 medications in pill-form, was a collaboration among federal, state, county and local partners, and received statewide recognition.

A total of 2,634 COVID-19 cases were reported to the county in the past seven days, compared to 2,840 infections the previous week. The cumulative total cases in the county increased to 919,938.

Leave a Reply

Your email address will not be published.